Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216742 · ClinicalTrials.gov registry record · Phase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
A Phase 3 study of Infertility (IVF Patients), sponsored by Granata Bio Corporation.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 659
- Enrollment target
- 16
- Study locations
NCT07216742: Recruiting Phase 3 study of Infertility (IVF Patients), sponsored by Granata Bio Corporation.
NCT07216742 is a Phase 3 study of Infertility (IVF Patients) that is actively recruiting participants, run by Granata Bio Corporation. The registered enrollment target is 659 participants, above the 406-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (62% higher). The trial reports 16 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216742, a Phase 3 study of Infertility (IVF Patients), is actively recruiting participants, sponsored by Granata Bio Corporation.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 659 participants
- Enrollment target
- 16
- Study locations
Study Summary
The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (ART) cycle in in women with a diagnosis of infertility.
Primary Outcome
cumulative live birth rate following vitrified-thawed, single-euploid blastocyst transfer(s)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG hMG subcutaneous injection
Study Locations (16)
Florida
- IVF Florida Reproductive Associates - Margate
- Center for Reproductive Medicine - Winter Park
North Carolina
- Reach Fertility - Charlotte
- Carolina Conceptions - Raleigh
Texas
- CARE Fertility - Bedford
- Shady Grove Houston - Webster
California
- HRC Fertility - Encino
Connecticut
- Illume Fertility - Norwalk
Delaware
- Reproductive Associates of Delaware CCRM - Newark
Georgia
- Reproductive Biology Associates (RBA) - Atlanta
Hawaii
- Fertility Institute of Hawaii - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 659 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2028-11 |
| Phase | Phase 3 |
What NCT07216742 shows while recruiting
NCT07216742 is an interventional study that assigns participants to a tested intervention. The registered 659 participants enrollment target is mid-sized for trials with a published cap, above the 406-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (62% higher).
The record links to 1 condition, with Infertility (IVF Patients) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07216742 lists 16 locations in 13 states (Florida, North Carolina, Texas).
Frequently Asked Questions
What is clinical trial NCT07216742 about?
NCT07216742 is a clinical study titled "Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.". The goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reproductive Technology (A...
What is the current status of trial NCT07216742?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 659 participants. The study started on 2025-11-01. Estimated completion is 2028-11.
What conditions does trial NCT07216742 study?
This clinical trial studies the following conditions: Infertility (IVF Patients).
What interventions are being tested in trial NCT07216742?
The interventions under investigation include: Placebo (DRUG), hMG subcutaneous injection (DRUG).
Who is sponsoring clinical trial NCT07216742?
This trial is sponsored by Granata Bio Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216742 being conducted?
This trial has 16 study locations across California, Connecticut, Delaware, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility (IVF Patients)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07216742's enrollment target sits among peer trials
659 4th of 9 higher than 6 of 9 other Infertility (IVF Patients) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility (IVF Patients) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
RECRUITING · Phase 3
-
Quantifying Uterine Elastography in Menstruating Women
RECRUITING
-
The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
RECRUITING · NA
-
Male Infertility and Assisted Reproductive Technologies Research Biobank
RECRUITING
-
Ketorolac Use and Fresh Embryo Transfer Outcomes
RECRUITING · Phase 4
-
Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI